Danaher Corporation (NYSE:DHR) stock has experienced a notable downturn, reaching a 52-week low of $225.36. With a market ...

Danaher (DHR) stock trades ~5% lower as the company, with its Q4 2024 results, projects a sales contraction in the current ...

Danaher's Q4 earnings missed expectations due to a decline in its diagnostics segment, despite stronger sales in ...

Stifel analysts reduced the price target for Danaher Corporation shares (NYSE:DHR) to $260 from the previous target of $265, while maintaining a Hold rating on the stock. The new target sits within ...

1 Day DHR 1.95% DJIA 0.65% S&P 500 -1.46% Health Care/Life Sciences -0.52% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

U.S. stocks slipped after the Federal Reserve held its main interest rate steady and broke a run of cuts that began in ...

Quarterly orders topped estimates, as companies scrambled to get their hands on machinery to make increasingly sophisticated semiconductors. U.S.-listed ASML sto ...

WASHINGTON (AP) — WASHINGTON (AP) — Danaher Corp. (DHR) on Wednesday reported fourth-quarter net income of $1.09 billion. The Washington-based company said it had profit of $1.49 per share. Earnings, ...

This positive outcome has rippled through the industry, with Danaher and Thermo Fisher anticipating their own earnings reports later this week. Analysts have weighed in on Sartorius's results, ...

Shares of Danaher Corp. DHR slid 0.94% to $237.62 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.11% to 5,842.91 and ...